Synonyms Acquired Progressive Lymphangioma, Acquired progressive lymphangioma, Acquired progressive lymphangioma (disorder) + [35] |
Introduction A benign tumor resulting from a congenital malformation of the lymphatic system. Lymphangioendothelioma is a type of lymphangioma in which endothelial cells are the dominant component. |
Target |
Mechanism mTOR inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date15 Sep 1999 |
Target |
Mechanism TLR modulators [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. KR |
First Approval Date03 Jan 1995 |
Target |
Mechanism TLR4 agonists |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date01 Oct 2024 |
Sponsor / Collaborator |
Start Date20 Nov 2022 |
Sponsor / Collaborator- |
Start Date27 Oct 2021 |
Sponsor / Collaborator- |